Assignee
SYNBIAS PHARMA AG
CH·4 granted patents·4 pending applications·2 citations·filing 2013–2019
Top patents by PatentIndex Score
8 records- 0166US10030043B2Method for the synthesis of clofarabineSYNBIAS PHARMA AG·Filed 2015·Granted Jul 24, 2018·2 cites·8 claims
- 0250US9765083B2Method for the synthesis of irinotecanSYNBIAS PHARMA AG·Filed 2014·Granted Sep 19, 2017·0 cites·7 claims
- 0349US2019382432A1Stable crystalline monohydrate of epirubicin hydrochloride and method of productionSYNBIAS PHARMA AG·Filed 2019·Application pending·0 cites
- 0447US10526290B2Bendamustine derivatives and related compounds, and medical use thereof in cancer therapySYNBIAS PHARMA AG·Filed 2013·Granted Jan 7, 2020·0 cites·7 claims
- 0536US2020323838A1Lenalidomide immediate release formulationsSYNBIAS PHARMA AG·Filed 2018·Application pending·0 cites
- 0632US10308665B2Method for the synthesis of rapamycin derivativesSYNBIAS PHARMA AG·Filed 2016·Granted Jun 4, 2019·0 cites·14 claims
- 0724US2019092792A1Vinorelbine monotartrate and its pharmaceutical useSYNBIAS PHARMA AG·Filed 2016·Application pending·0 cites
- 0824US2018201966A1Method for the synthesis of pentostatinSYNBIAS PHARMA AG·Filed 2016·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →